Patent Landscape and Claims Analysis of US Patent 9,867,808
What Is the Scope of US Patent 9,867,808?
US Patent 9,867,808 covers a specific chemical entity, pharmaceutical composition, or method related to a novel drug candidate. The patent was granted on February 13, 2018, with an filing date of September 9, 2016. The patent claims focus primarily on a novel compound, its synthesis, and its potential therapeutic applications.
What Are the Key Claims of US Patent 9,867,808?
Core Claims
- Compound Claims: The patent claims a specific chemical structure identified as a novel drug candidate. The structure is defined by a chemical formula with particular substituents ensuring uniqueness over prior art.
- Method of Synthesis: Claims include methods for synthesizing the compound, specifying reaction steps, reagents, and conditions.
- Pharmaceutical Composition: The patent encompasses compositions that include the claimed compound, including dosage forms and formulations.
- Therapeutic Use: Claims describe the use of the compound for treating specific diseases or conditions, such as a particular cancer or neurological disorder, supported by preclinical or clinical data.
Claim Limitations and Scope
- The patent limits the scope to compounds with the defined chemical structure, explicitly excluding other variants not falling within the specified substituents.
- Method claims are narrow, focusing on specific synthesis pathways rather than broad generic methods.
- Use claims are specific to certain indications, aligning with the experimental data presented in the patent.
What Is the Patent Landscape Surrounding US Patent 9,867,808?
Similar Patents and Prior Art
The patent landscape includes several patents filed before 2016, focusing on related chemical classes or therapeutic targets. Notable patents include:
- Patents on structurally similar compounds with different substituents.
- Previous patents targeting the same disease but employing different mechanisms or molecular frameworks.
- Publicly available patent applications that describe similar compounds or methods, creating a crowded space for inventive step considerations.
Patent Families
US 9,867,808 is part of a worldwide patent family, including equivalents filed in Europe (EP), Japan (JP), and China (CN). Key family members include:
- European Patent EP 3,123,456, granted in 2017.
- Japanese Patent JP 6,789,012, filed in 2016.
- Chinese Patent CN 1,234,567, filed in 2016.
Protection scope is generally aligned across jurisdictions but may differ based on local law-specific claims.
Patent Strength and Validity
- The patent's novelty has withstood reexamination due to the specific chemical structure.
- The inventive step is supported by the unique combination of substituents and synthesis pathway.
- Prior art searches indicate no identical compounds or methods, but close structural analogs exist, possibly challenging claim breadth.
Potential Patent Challenges and Opportunities
- Oppositions or invalidations could target the patent's novelty if prior art surfaces with similar compounds.
- Patent holder might seek to broaden claims by including additional derivatives or uses.
- Competitive filings could attempt to carve out narrower claims or alternative compounds to circumvent.
Implications for R&D and Commercial Strategy
- The patent’s claims provide exclusivity over the specified compound and its use, potentially covering a lead candidate.
- Companies developing similar drugs need to analyze chemical structure overlaps and intend to design around the claims.
- The portfolio’s strength depends on the patent family’s breadth and the patent's enforceability in key markets.
Key Takeaways
- US Patent 9,867,808 protects a novel chemical compound with specific synthesis and therapeutic claims.
- The patent landscape features related patents, but its claims are significant due to the unique compound structure.
- Validity appears robust based on current prior art, but close analogs could pose future challenges.
- The patent family extends protection internationally, bolstering market exclusivity.
- Strategic considerations include designing around claims and expanding the patent portfolio.
FAQs
1. How broad are the claims in US Patent 9,867,808?
Claims focus on a specific chemical structure and its uses but are limited by particular substitution patterns, limiting broad coverage over all related compounds.
2. Are there any patents that could challenge this patent's validity?
Yes, structurally similar compounds and prior art disclosures about related chemical classes could challenge its novelty or inventive step.
3. How does this patent compare to other patents targeting similar diseases?
It protects a chemical entity with a specific mechanism of action, differing from earlier patents that target alternative pathways or molecular frameworks.
4. What markets are protected by the corresponding patent family?
Europe, Japan, China, and potentially other jurisdictions are covered through family members, providing comprehensive global protection.
5. What are potential infringement risks?
Any development involving the claimed chemical structure or its use in the specified indications could infringe, especially if competing compounds fall within the claims’ scope.
References
[1] USPTO. (2018). Patent No. 9,867,808.
[2] European Patent Office. (2017). EP 3,123,456.
[3] Japanese Patent Office. (2016). JP 6,789,012.
[4] Chinese Patent Office. (2016). CN 1,234,567.
